5 completed, 1 recruiting, 1 terminated, 1 unknown. 8 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 5, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow Neoplasm: new trials by email Literature Review of Neoplasm trials Research Report on Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Enhancing Successful Return to Work of Employees With Cancer, by Supporting Employers (MiLES Intervention) MiLES - Cancer, Neoplasm | Phase 2 / Phase 3 | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 140 | 2023-12-18 | 2024-11-04 |
| Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban rivaroxaban, Low-molecular-weight heparin - Neoplasm, Venous Thromboembolism | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 159 | 2016-09-01 | 2018-08-13 |
| Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide Polihexanide 2%, Metronidazole 0.8% - Neoplasm, Wounds and Injuries | Phase 3 | Completed | University of Sao Paulo | 24 | 2013-09-01 | 2015-09-02 |
| Cancers Treated With Combination of Antrodia Cinnamomea and Chemotherapy AC-Can, placebo - Neoplasm, Functional Gastrointestinal Disorder | Phase 2 / Phase 3 | Unknown | Chang Gung Memorial Hospital | 64 | 2010-06-01 | 2011-02-08 |
| A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine Tapentadol in the Titration Phase, Morphine in the Maintenance Phase, Matching Placebo in the Maintenance Phase after Tapentadol in the Titration Phase - Pain, Neoplasm | Phase 3 | Terminated | Grünenthal GmbH | 136 | 2007-06-01 | 2019-11-01 |
| Iressa Expanded Access Program (EAP) ZD1839 (Gefitinib) - Carcinoma, Non-small-cell Lung | Phase 3 | Completed | AstraZeneca | 2000-08-01 | 2013-01-04 | |
| Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy Epoetin alfa - Anemia, Cancer | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 375 | 1996-08-01 | 2011-05-18 |
| The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy epoetin alfa - Anemia, Multiple Myeloma | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 201 | 1995-02-01 | 2011-05-18 |
Neoplasms (8) · Anemia (2) · Breast Neoplasms (1) · Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Esophageal Neoplasms (1) · Gastrointestinal Diseases (1) · Lymphoma (1) · Multiple Myeloma (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1) · Pain (1) · Prostatic Neoplasms (1) · Small Cell Lung Carcinoma (1) · Venous Thromboembolism (1)
Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Cardiovascular Diseases (2) · Digestive System Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Lung Diseases (2) · Lung Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Pathological Conditions, Signs and Symptoms (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Vascular Diseases (2)
Epoetin Alfa (2) · Dalteparin (1) · Gefitinib (1) · Heparin, Low-Molecular-Weight (1) · Masks (1) · Morphine (1) · Rivaroxaban (1) · Tapentadol (1)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Assistance Publique - Hôpitaux de Paris (1) · AstraZeneca (1) · Chang Gung Memorial Hospital (1) · Grünenthal GmbH (1) · University of Sao Paulo (1)
France (2) · United States (2) · Argentina (1) · Brazil (1) · Chile (1) · Latvia (1) · Netherlands (1) · Taiwan (1) · Ukraine (1)
Guy Meyer, MD (1) · P. Poulain, Dr. (1) · Sietske Tamminga, PhD (1) · Yu-Chiang Hung, MD, PhD (1)